NORFOLK COUNTY, ON, Dec. 11, 2018 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Target Group Inc. (OTCQB: CBDY) today announced that its wholly owned subsidiary, Canary Rx Inc. (“Canary”) has entered into an exclusive global partnership agreement with Serious Seeds B.V. in all legal cannabis markets (“Serious Seeds”). Serious Seeds is a world renowned and highly acclaimed Dutch seed bank known for breeding premium cannabis strains, including AK-47, Chronic, Bubblegum, Kali Mist and White Russian.Continue Reading
TORONTO, ON, Dec. 04, 2018 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Target Group Inc. (OTCQB:CBDY) is very excited to announce today that it has entered into a Letter of Intent to acquire 100% ownership of Massachusetts-based CannaKorp, Inc. (“CannaKorp”) for its patent-pending WISP™ Vaporizing system.Continue Reading
TORONTO, ON, Nov. 01, 2018 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Target Group Inc. (OTCQB:CBDY) today announced it has retained Investor Relations expert Todd D. Sonoga, to spearhead our investment community awareness efforts.Continue Reading
NORFOLK COUNTY, ON, Oct. 30, 2018 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Target Group Inc. (OTCQB: CBDY) today announced that its wholly owned subsidiary, Canary Rx Inc. (“Canary”) (the “Company”) is pleased to provide an update on construction progress at the Company’s 44,000 square foot Norfolk County cannabis cultivation facility.Continue Reading
TORONTO, ON, Oct. 24, 2018 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Target Group Inc. (OTCQB: CBDY) today announced an exclusive licensing, distribution and central processing agreement for Canada and Europe with Massachusetts-based CannaKorp Inc. (“CannaKorp”) for its patent-pending Wisp Vaporizing system.Continue Reading
TORONTO, Oct. 23, 2018 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Target Group Inc. (“Target” or the “Company”) (OTC: CBDY) announced today that after a successful application to up-list from the OTC Pink Market, its Common shares have been upgraded to a listing on the OTCQB (“OTCQB”) Venture Market, trading under the ticker symbol “CBDY.” “We are very enthusiastic to be upgraded to a listing on the OTCQB Venture Market for early stage and developing U.S. and international companies. This new listing allows U.S. investors the opportunity to further share in the Company’s continued expansion and growth internationally,” said Rubin Schindermann, CEO and Director of Target. “U.S. investors can obtain Real-Time quotes and market information for the Company at www.otcmarkets.com and access the most current company news and developments.”Continue Reading
Toronto, Aug. 08, 2018 (GLOBE NEWSWIRE) — Effective August 2, 2018, Target Group Inc. (CBDY) completed the acquisition of all of the issued and outstanding common stock of Visava Inc. (“Visava”). Pursuant to the Agreement and Plan of Share Exchange dated June 27, 2018, the Company will issue 25,500,000 shares of its common stock to the Visava shareholders, plus warrants to purchase up to an additional 25,000,000 shares of the Company’s common stock at $0.10 per share for a period of two years from the date of closing. Visava, an Ontario, Canada corporation, will continue to operate as a wholly-owned subsidiary of the Company.Continue Reading
Toronto, Ontario, July 10, 2018 (GLOBE NEWSWIRE) — Effective June 27, 2018, Target Group Inc. (CBDY) (the Company) entered into an Agreement and Plan of Share Exchange (“Exchange Agreement”) with Visava Inc., a private Ontario, Canada corporation (“Visava”). Visava owns 100% of Canary Rx Inc., a Canadian corporation that is a late stage ACMPR applicant with Health Canada. Canary Rx Inc. holds a leasehold interest in a 40,000 sq. ft. parcel of property located in Ontario’s Norfolk County for the production of approximately 3,600,000 gr. of cannabis per year. On June 27, 2018, Canary Rx Inc. received a letter of readiness from Health Canada and will finish the buildout of the 40,000 sq. ft. facility within the next 90-120 days.Continue Reading
Canary Rx Inc. (“Canary”) is pleased to announce that it has received a ‘Letter of Readiness’ in response to its application to become a licensed producer (“LP”) under Health Canada’s Access to Cannabis for Medical Purposes Regulations (“ACMPR”).
Construction at Canary’s 40,000 sq ft, Norfolk County facility continues, and is estimated to be complete within 90-120 days.Continue Reading
One of the key requirements of the Access to Cannabis for Medical Purposes Regulations (ACMPR) is that Licensed Producers keep detailed records of virtually every aspect of operations. This comprehensive record keeping is managed by technology the industry refers to as ‘seed-to-sale software’.
Canary has selected Ample Organics as our seed-to-sale platform. Their industry leading software was developed exclusively for the cannabis market, ensuring complete compliance with ACMPR regulations. Ample Organic’s technology manages all aspects of operations from production, inventory and quality assurance, to security, processing, packaging and sales. Boasting Canada’s largest cannabis data collection, with over 80% of Canada’s medical patients, and more than 16 million grams of cannabis tracked, Ample Organics is the gold standard in cannabis software solutions.Continue Reading